Manulife Financial Corp (MFC) 14.12 $MFC Manulife Asset

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Manulife Financial Corp (MFC) 14.12 $MFC

Manulife Asset Management names Chris Fellingham as Head of Liquid Alternative Strategies
CNW Group - Thu Jun 09, 9:16AM CDT
Manulife Asset Management, the investment management arm of Manulife Financial Corporation (TSX, NYSE: MFC), has named Chris Fellingham as Senior Managing Director, Head of Liquid Alternative Strategies. The appointment is effective June 13. Mr. Fellingham will report to Chris Conkey, Executive Vice President, Global CIO, Manulife Asset Management, and be based in London.
MFC: 14.12 (-0.47)

First Graduates of Year-Long EPIC Program Find Increased Self-Awareness and Confidence
PR Newswire - Wed Jun 08, 11:53AM CDT
Yesterday, forty-six at-risk youth, 11-14 years old, became the first graduating class of EPIC: Enhancing Potential, Inspiring Change. The program was developed to address a need identified by Mayor Walsh for providing a positive experience for youth in the age group during what can be a difficult time of transition and change.
MFC: 14.12 (-0.47), MFC.TO: 18.02 (-0.53)

EDF EN Canada Sells a 50% Stake in the Mont Rothery Wind Project
BusinessWire - Wed Jun 08, 9:32AM CDT
EDF EN Canada Inc., a subsidiary of EDF Energies Nouvelles Group, today announced that they have closed on the Asset Purchase Agreement with MD1 WIND LP, a limited partnership formed by a consortium (the "Consortium" of four affiliated entities of the Desjardins Group ("Desjardins", including Desjardins Group Pension Plan, and Manulife Financial Corporation ("Manulife", to divest to the Consortium, a 50% interest in the 74 megawatt (MW) Mont Rothery Wind Project.
MFC: 14.12 (-0.47), MFC.TO: 18.02 (-0.53)

Fitch Assigns Manulife Financial's New Sr. Unsecured Notes Expected Rating of 'A-(EXP)'
BusinessWire - Tue Jun 07, 3:50PM CDT
Fitch Ratings has assigned an expected rating of 'A-(EXP)' to Manulife Financial Corporation (MFC) USD1.0 billion 4.7% senior notes due 2046. The offering took place in Taiwan and is expected to close on June 23, 2016.
MFC: 14.12 (-0.47)

Manulife Announces USD Senior Notes Issue in Taiwan
PR Newswire Europe - Tue Jun 07, 9:13AM CDT
TORONTO, June 7, 2016 /PRNewswire/ --
MFC: 14.12 (-0.47), MFC.TO: 18.02 (-0.53)

Manulife Financial Corporation announces results of Conversion Privilege of Non-cumulative Rate Reset Class 1 Shares Series 3
CNW Group - Tue Jun 07, 8:14AM CDT
C$ unless otherwise stated
MFC: 14.12 (-0.47), MFC.TO: 18.02 (-0.53)

John Hancock Investments launches two ESG funds
PR Newswire - Mon Jun 06, 8:00AM CDT
John Hancock Investments today announced the addition of two new funds focused on integrating environmental, social, and governance (ESG) issues with fundamental stock research. John Hancock ESG All Cap Core Fund and John Hancock ESG Large Cap Core Fund are both managed by Trillium Asset Management, LLC, the country's oldest investment advisor exclusively focused on sustainable and responsible investing.
MFC: 14.12 (-0.47), MFC.TO: 18.02 (-0.53)

Lincoln Financial Launches Economical Insurance Product (revised)
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 2:56PM CDT
LNC recently launched Lincoln TermAccel Level Term insurance to facilitate advisors in providing more affordable insurance protection.
MFC: 14.12 (-0.47), GWGH: 7.07 (-0.22), LNC: 43.04 (-1.29)

Torchmark's Growth Initiatives Impress, High Expenses a Drag
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 9:06AM CDT
On Jun 3, we issued an updated research report on Torchmark Corporation (TMK).
TMK: 60.18 (-0.46), HIIQ: 4.55 (-0.62), MFC: 14.12 (-0.47), SLF: 34.20 (-0.72)

Manulife Investing in Toronto Real Estate Investment & Property Management Firm
PR Newswire - Thu Jun 02, 3:11PM CDT
-- Company Taking 49% Stake in Q Management LP (QMLP), the Multi-Family Asset and Property Management Entities of Privately-Held Conundrum Capital Corporation
MFC: 14.12 (-0.47), MFC.TO: 18.02 (-0.53)

5 Best PEG Stocks Value Investors Will Love Right Now
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 9:29AM CDT
It is not difficult to realize the huge significance of the "intrinsic value" of a stock.
TSE: 48.32 (-0.19), MFC: 14.12 (-0.47), DF: 17.78 (-0.49), TPC: 23.12 (+1.12)

Reinsurance Group (RGA) Offers Senior Notes & Debentures
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 8:08AM CDT
Reinsurance Group of America, Incorporated (RGA) has announced two new debt offerings.
HIIQ: 4.55 (-0.62), MFC: 14.12 (-0.47), GWGH: 7.07 (-0.22), RGA: 96.58 (-1.61)

John Hancock Closed-End Funds Declare Quarterly Distributions
PR Newswire - Wed Jun 01, 3:58PM CDT
The five John Hancock closed-end funds listed below declared their quarterly distributions today as follows:
HTY: 10.33 (-0.30), JHS: 14.46 (-0.08), MFC: 14.12 (-0.47), HEQ: 14.87 (-0.18), MFC.TO: 18.02 (-0.53), JHI: 15.69 (+0.04), BTO: 26.00 (-0.65)

John Hancock Closed-End Funds Declare Monthly Distributions
PR Newswire - Wed Jun 01, 3:57PM CDT
The five John Hancock closed-end funds listed below declared their monthly distributions today as follows:
HTD: 24.47 (-0.10), HPI: 22.66 (-0.08), PDT: 16.05 (-0.03), MFC: 14.12 (-0.47), MFC.TO: 18.02 (-0.53), HPF: 22.13 (-0.15), HPS: 19.36 (-0.25)

Lincoln Financial Launches Economical Insurance Product
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 8:52AM CDT
Lincoln National Corporation (LNC) recently launched Lincoln TermAccel Level Term insurance to facilitate advisors in providing more affordable insurance protection.
HIIQ: 4.55 (-0.62), MFC: 14.12 (-0.47), GWGH: 7.07 (-0.22), LNC: 43.04 (-1.29)

John Hancock Strategic Income Opportunities Fund Marks Tenth Anniversary
PR Newswire - Wed Jun 01, 7:55AM CDT
John Hancock Investments in April marked the tenth anniversary of the inception of John Hancock Strategic Income Opportunities Fund, a go-anywhere multi-sector bond fund managed by John Hancock Asset Management and, with $5.5 billion in assets as of March 31, 2016, the largest fixed-income fund in the John Hancock Investments lineup.
MFC: 14.12 (-0.47), MFC.TO: 18.02 (-0.53)

John Hancock Premium Dividend Fund Notice To Shareholders - Sources Of Distribution Under Section 19(a)
PR Newswire - Tue May 31, 4:15PM CDT
John Hancock Premium Dividend Fund (NYSE: PDT) (the "Fund", a closed-end fund managed by John Hancock Advisers, LLC and subadvised by John Hancock Asset Management a division of Manulife Asset Management (US) LLC, announced today sources of its monthly distribution of $0.0900 per share paid to all shareholders of record as of May 12, 2016, pursuant to the Fund's managed distribution plan.
PDT: 16.05 (-0.03), MFC: 14.12 (-0.47), MFC.TO: 18.02 (-0.53)

Lincoln National Increases Share Buyback Program to $1B
Zacks Equity Research - Zacks Investment Research - Tue May 31, 8:17AM CDT
The board of directors of Lincoln National (LNC) increased the company's share buyback program. With the new approval, the company is authorized to repurchase shares up to $1 billion.
HIIQ: 4.55 (-0.62), MFC: 14.12 (-0.47), SLF: 34.20 (-0.72), LNC: 43.04 (-1.29)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 364

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 157

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 160

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 147

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 170

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading

Top 5 Most Recently Viewed Articles

Genmab's Ongoing Share Buy-back Program Details and Impact

Updated Category News Views 119

Introduction to the Share Buy-back Program In a recent announcement, Genmab A/S (NASDAQ: GMAB) revealed that it has initiated an ambitious share buy-back program. This initiative aims to repurchase up to 2.2 million shares, which is a strategic step not just to reduce capital but also to fulfill commitments under the Restricted Stock Unit program. The company anticipates...

Continue Reading
Allego Strengthens Leadership with New Innovative CTO

Updated Category News Views 159

Allego Appoints Holger Riemenschneider as Chief Technology Officer Allego N.V. (NASDAQ: ALGO) has recently appointed Holger Riemenschneider as its Chief Technology Officer. This move is a significant step for the company, which has rapidly established itself as a leading name in the electric vehicle (EV) charging industry. With Holger on board, Allego is looking to...

Continue Reading
Exploring the Growth Drivers of Semiconductor Fabrication Software

Updated Category News Views 167

Understanding the Semiconductor Fabrication Software Market The Semiconductor Fabrication Software market is on the brink of significant transformation, with projections indicating a remarkable growth of approximately USD 984.91 million from 2024 to 2028. This growth is primarily fueled by the rising complexity of semiconductor designs in conjunction with the impact of...

Continue Reading
Ohmyhome Prepares to Share Exciting Q3 2024 Growth Insights

Updated Category News Views 45

Ohmyhome Set to Unveil Q3 2024 Growth Insights As a leading property technology platform, Ohmyhome Ltd. (NASDAQ: OMH) has established itself as a prominent player in the real estate market. The company specializes in offering comprehensive solutions ranging from brokerage, renovation, and management services for properties in the region. As consumers increasingly look for...

Continue Reading
Eli Lilly Prepares for Major Breast Cancer Data Presentation

Updated Category News Views 220

Introduction to Eli Lilly's Breast Cancer Initiatives At the upcoming San Antonio Breast Cancer Symposium (SABCS), Eli Lilly and Company (NYSE: LLY) is set to unveil groundbreaking data that enhances its portfolio in breast oncology. The symposium, running from December 9 to 12, serves as a platform for Lilly to highlight advancements in treatments for hormone...

Continue Reading